HarmonyFidelisHarmonyFidelis
Login
NewsMajor ProjectsActorsAcademy
Back to actors

Actor profile / Company

Neuralink

Neuralink Corp.

Mission : Pioneering brain-computer interfaces to restore autonomy and communication.

AboutSources & documents

AI-generated conceptual illustration of the field; not a photograph of this actor or its facilities.

Founded
2016
Headquarters
United States
Status
Active

Technology & contribution

Neurotechnology company developing an implantable brain-computer interface. Its clinical studies assess the safety and function of the N1 implant and R1 surgical robot, followed by their use to control assistive devices or restore communication.

Technologies & applications

  • Brain-computer interfaces
  • N1 implant
  • R1 surgical robot
  • Assistive technologies
  • Early-stage clinical trials

Development & current work

Milestones are ordered; spacing does not represent elapsed time. Future dates are announced targets.

  1. 2024

    PRIME: feasibility study in people with tetraplegia

    Active

    Early-stage clinical study still recruiting in January 2026. It primarily assesses the clinical safety and function of the wireless, rechargeable N1 implant, placed by the R1 robot to enable control of external devices.

    [2]
  2. 2024

    CONVOY: control of assistive devices

    Active

    Invitation-only study for PRIME participants. It assesses the feasibility, consistency and safety of neural control of a robotic arm and other assistive devices.

    [3]
  3. 2025

    VOICE: restoring communication

    Active

    Recruiting early-stage study assessing the initial safety and effectiveness of the N1 and R1 systems for communication in adults with severe, irreversible speech-production impairment.

    [4]

Ecosystem participation

Biotechnology & Synthetic Biology

Organisation & documentary record

Legal identity

Legal name
Neuralink Corp.
Status
Active
Verified on
2026-08-30
Review due
2026-11-30
Neuralink Corp.

Sources & documents

References are attached to the claims they support. Institutional documents describe the author’s own work; they do not constitute independent validation.

  1. 01

    Official organization website

    Neuralink Corp.

    Verified on 2026-08-30

  2. 02

    PRIME: feasibility study in people with tetraplegia

    clinicaltrials.gov

    Verified on 2026-08-25

  3. 03

    CONVOY: control of assistive devices

    clinicaltrials.gov

    Verified on 2026-08-25

  4. 04

    VOICE: restoring communication

    clinicaltrials.gov

    Verified on 2026-08-25

  5. 05

    Neuralink clinical trials

    neuralink.com